News for LifeMD, Inc. (LFMD)

LifeMD (LFMD) has announced a significant expansion in its insurance coverage, now accepting Medicare for qualifying care. The new offering initially targets mo

LifeMD's virtual care services now available to over 21 million Medicare Part B beneficiaries in 26 states, with 49-state access to qualifying services expecte

Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results

LifeMD's growth accelerates with expanded insurance, new health products, and a 43% revenue boost. Click here to read our most recent analysis of LFMD.

Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.

On March 14, 2025, Jessica Friedeman, Chief Marketing Officer of LifeMD Inc's subsidiary, sold 30,000 shares of LifeMD Inc (LFMD). Following this transaction, t

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Massachusetts-based 2seventy bio, Inc. (TSVT), a cell and gene therapy company is up over 76 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Operator: Good afternoon. Thank you for joining us to discuss LifeMD, Inc. Fourth Quarter and Full Year 2024 Earnings Results.

U.S. stock futures rose on Tuesday following Monday's heavy selloff. Futures of all four benchmark indices surged in premarket trading.

Consolidated Revenue: $64.3 million for Q4 2024, a 43% increase year-over-year.Telehealth Revenue Growth: 60% increase year-over-year.Adjusted EBITDA: $9 milli

Mar 10, 2025 / 08:30PM GMTOperator Good afternoon. Thank you for joining us to discuss LifeMD Inc fourth-quarter and full-year 2024 earnings results. Joining th

LifeMD, Inc. (NASDAQ:LFMD) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief Executive...

**media[562511]**

LifeMD (LFMD) delivered earnings and revenue surprises of 66.67% and 12.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir Technologies, Inc.

LifeMD (LFMD) Q4 earnings report is on March 10th. Analysts expect $0.14 EPS (-6.7% Y/Y) & $57.43M revenue (+28% Y/Y).

LifeMD Inc (LFMD) is set to release its Q4 2024 earnings on March 10, 2025. The consensus estimate for Q4 2024 revenue is $57.38 million, and the earnings are e

Healthcare services companies LifeMD (LFMD) and Teladoc Health (TDOC) announced partnerships with Eli Lilly's (LLY) direct-to-consumer platform.